- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
76 T-Cell Lymphoma Trials Near You
Power is an online platform that helps thousands of T-Cell Lymphoma patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerDuvelisib/CC-486 + Chemotherapy for Lymphoma
Trial Details
Key Eligibility Criteria
170 Participants Needed
Brentuximab + Chemotherapy for T-Cell Lymphoma
Trial Details
Key Eligibility Criteria
48 Participants Needed
Tagraxofusp for Blood Cancers
Trial Details
Key Eligibility Criteria
54 Participants Needed
DR-01 for Leukemia and Lymphoma
Trial Details
Key Eligibility Criteria
69 Participants Needed
KT-333 for Lymphoma and Cancer
Trial Details
Key Eligibility Criteria
120 Participants Needed
Pacritinib for T-Cell Lymphoma
Trial Details
Key Eligibility Criteria
100 Participants Needed
Trial Details
Key Eligibility Criteria
40 Participants Needed
Trial Details
Key Eligibility Criteria
6 Participants Needed
Romidepsin + Parsaclisib for Lymphoma
Trial Details
Key Eligibility Criteria
5 Participants Needed
Trial Details
Key Eligibility Criteria
21 Participants Needed
Romidepsin Combination Therapy for Lymphoma
Trial Details
Key Eligibility Criteria
23 Participants Needed
CPI-818 for T-Cell Lymphoma
Trial Details
Key Eligibility Criteria
151 Participants Needed
DS-3201b for Lymphoma
Trial Details
Key Eligibility Criteria
100 Participants Needed
HMPL-306 for Blood Cancers
Trial Details
Key Eligibility Criteria
75 Participants Needed
Nanatinostat + Valganciclovir for EBV-Positive Lymphoma
Trial Details
Key Eligibility Criteria
140 Participants Needed
Trial Details
Key Eligibility Criteria
12 Participants Needed
Trial Details
Key Eligibility Criteria
30 Participants Needed
Combination Chemotherapy for T-Cell Leukemia/Lymphoma
Trial Details
Key Eligibility Criteria
1895 Participants Needed
Brentuximab + Lenalidomide for T-Cell Lymphoma
Trial Details
Key Eligibility Criteria
26 Participants Needed
Targeted Immunotherapy for Leukemia
Trial Details
Key Eligibility Criteria
30 Participants Needed
Why Other Patients Applied
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."
Imatinib + Chemotherapy for Acute Lymphoblastic Leukemia
Trial Details
Key Eligibility Criteria
475 Participants Needed
Sapanisertib for Acute Lymphoblastic Leukemia
Trial Details
Key Eligibility Criteria
16 Participants Needed
Combination Chemotherapy +/− Bortezomib for Lymphoma
Trial Details
Key Eligibility Criteria
847 Participants Needed
Trial Details
Key Eligibility Criteria
440 Participants Needed
SGR-1505 for B-Cell Lymphoma
Trial Details
Key Eligibility Criteria
52 Participants Needed
Tafasitamab + Lenalidomide/ICE for Large B-Cell Lymphoma
Trial Details
Key Eligibility Criteria
37 Participants Needed
Trial Details
Key Eligibility Criteria
422 Participants Needed
CRG-022 for Large B-Cell Lymphoma
Trial Details
Key Eligibility Criteria
101 Participants Needed
APG-115 + APG-2575 for Leukemia
Trial Details
Key Eligibility Criteria
78 Participants Needed
Cell Therapy for Non-Hodgkin's Lymphoma
Trial Details
Key Eligibility Criteria
248 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do T-Cell Lymphoma clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do T-Cell Lymphoma clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across T-Cell Lymphoma trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for T-Cell Lymphoma is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a T-Cell Lymphoma medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest T-Cell Lymphoma clinical trials?
Most recently, we added BAFF CAR-T Cells for Chronic Lymphocytic Leukemia, CAR T-Cell Therapy for Leukemia and Lymphoma and Needle-free Triamcinolone Acetonide Injection for Cutaneous Lymphoma to the Power online platform.